Intuitive Surgical Inc. ($ISRG) Stock Forecast: Up 6.9% Today

What is Intuitive Surgical Inc.?

Intuitive Surgical (ISRG) is a robotics giant recognized for its innovative surgical systems like the da Vinci and Ion. The company experienced a notable bullish movement in the market today.

Why is Intuitive Surgical Inc. going up?

ISRG stock is up 6.9% on Apr 22, 2026 17:16

• ISRG stock saw a drop despite surpassing first-quarter predictions and increasing full-year guidance, potentially due to the guidance raise falling short of market expectations, indicating a likely slowdown ahead.
• Although showing a robust performance in Q1, marked by a 23% surge in sales and notable growth in da Vinci and Ion procedures, ISRG's careful guidance overshadowed its achievements, contributing to the bearish market trend.
• Investors seemed to react to the disparity between the impressive earnings report and the company's conservative forecast, leading to a stock decline despite positive operational outcomes.
• The market sentiment surrounding ISRG seems to reflect a balance between present performance and future growth possibilities, resulting in a varied response from investors.

ISRG Price Chart

ISRG Technical Analysis

ISRG News

Danaher Corp Stock (DHR) Moved Down by 3.40% on Apr 22: A Full Analysis

Danaher Corp (DHR) stock fell by 3.40% despite beating first-quarter earnings expectations and raising its full-year earnings forecast. The decline is attributed to a revenue miss, flat organic growth, margin compression, and subsequent downward adjustments to price targets by analysts. Strengths in bioprocessing were offset by weaknesses in Cepheid and diagnostics, contributing to market caution.

https://www.tradingkey.com/news/market-movers/261811362-market-movers-dhr-20260422

M&T Bank Corp Has $321.16 Million Stake in Zimmer Biomet Holdings, Inc. $ZBH

M&T Bank Corp significantly increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 15,705.6% during the fourth quarter, now owning 3,571,595 shares valued at over $321 million. This makes Zimmer Biomet the 16th largest position in M&T Bank Corp's investment portfolio, representing approximately 1.0% of it. Other institutional investors like Dodge & Cox and AQR Capital Management also adjusted their holdings in Zimmer Biomet, reflecting broader institutional interest in the medical equipment provider.

https://www.marketbeat.com/instant-alerts/filing-mt-bank-corp-has-32116-million-stake-in-zimmer-biomet-holdings-inc-zbh-2026-04-22/

Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Boston Trust Walden Corp

Boston Trust Walden Corp reduced its stake in Zimmer Biomet Holdings, Inc. by 3.5% in the fourth quarter. Despite this, Zimmer Biomet reported strong Q4 results, beating revenue and EPS expectations, and announced a quarterly dividend of $0.24 per share. Various other institutional investors have either increased or initiated positions in the medical equipment provider.

https://www.marketbeat.com/instant-alerts/filing-zimmer-biomet-holdings-inc-zbh-shares-sold-by-boston-trust-walden-corp-2026-04-22/

Why Robotics Giant Intuitive Surgical Dropped Despite Its Beat And Raise

Intuitive Surgical (ISRG) stock experienced a drop despite beating first-quarter forecasts and raising its full-year guidance. This reaction is likely due to the guidance hike not being as substantial as the beat, suggesting the company anticipates a slowdown later in the year or is exercising caution in its outlook. The company's robotic surgery systems, including da Vinci and Ion, are central to its operations.

https://www.investors.com/news/technology/intuitive-surgical-stock-intuitive-surgical-earnings-q1-2026/

Intuitive sales increase 23% in Q1, da Vinci procedures expected to see double-digit growth in 2026

Intuitive Surgical reported strong first-quarter 2026 earnings, surpassing Wall Street expectations with a 23% increase in sales to $2.8 billion and profits of $821.5 million. The company's da Vinci surgical system saw 16% procedure growth, and the Ion endoluminal system grew by 39%. Intuitive anticipates continued double-digit growth for da Vinci procedures in 2026, alongside an increase in installed systems worldwide.

https://www.massdevice.com/intuitive-sales-increase-q1-2026/

Trending Today

Tilray Inc. ($TLRY) Stock Forecast: Down 5.3% Today

Incyte Corporation ($INCY) Stock Forecast: Up 1.3% Today

Applied Materials Inc. ($AMAT) Stock Forecast: Down 5.0% Today

Credo Technology Group ($CRDO) Stock Forecast: Down 7.3% Today

United Parcel Service Inc. ($UPS) Stock Forecast: Down 4.9% Today

ON Semiconductor Corporation ($ON) Stock Forecast: Down 5.2% Today

Alcoa Corporation ($AA) Stock Forecast: Down 5.1% Today

Universal Health Services Inc. ($UHS) Stock Forecast: Down 6.9% Today

Albemarle Corporation ($ALB) Stock Forecast: Down 5.1% Today

Packaging Corporation of America ($PKG) Stock Forecast: Up 3.1% Today

Intuitive Surgical Inc. Price History

22.03.2026 - ISRG Stock was up 6.9%

• ISRG stock saw a drop despite surpassing first-quarter predictions and increasing full-year guidance, potentially due to the guidance raise falling short of market expectations, indicating a likely slowdown ahead.
• Although showing a robust performance in Q1, marked by a 23% surge in sales and notable growth in da Vinci and Ion procedures, ISRG's careful guidance overshadowed its achievements, contributing to the bearish market trend.
• Investors seemed to react to the disparity between the impressive earnings report and the company's conservative forecast, leading to a stock decline despite positive operational outcomes.
• The market sentiment surrounding ISRG seems to reflect a balance between present performance and future growth possibilities, resulting in a varied response from investors.

22.03.2026 - ISRG Stock was up 5.7%

• Despite surpassing first-quarter forecasts and raising full-year guidance, Intuitive Surgical (ISRG) stock exhibited strong bullish momentum. The positive market response can be explained by several factors:
• The company posted robust first-quarter earnings, achieving a 23% sales increase to $2.8 billion and profits of $821.5 million, exceeding market expectations.
• Sales growth was primarily fueled by a 16% rise in da Vinci surgical system procedures and a 39% increase in the Ion endoluminal system.
• Intuitive Surgical's optimistic outlook, anticipating sustained double-digit growth for da Vinci procedures in 2026 and an expansion of installed systems globally, likely influenced the bullish market trend. The company's solid financial performance and favorable earnings report further enhanced investor confidence in its future outlook.

04.01.2026 - ISRG Stock was down 5.1%

• Machina Capital S.A.S. and other significant institutional investors have notably increased their holdings in ISRG, signaling confidence in the company's future.
• Despite positive Q3 performance and strategic growth positioning, ISRG witnessed a bearish movement, potentially attributed to profit-taking or shifts in market sentiment.
• The upcoming earnings release from Zimmer Biomet Holdings (ZBH) might have impacted market dynamics, leading to a more cautious approach towards medical equipment stocks like ISRG.
• Market sentiments surrounding healthcare and medical technology sectors likely influenced ISRG's bearish movement, despite its favorable long-term growth prospects.

10.11.2025 - ISRG Stock was down 2.8%

• An institutional investor increased its stake in ISRG by 1.2% in Q2, despite recent insider selling by executives, following the company's strong Q3 earnings.
• Another institutional investor, Daiwa Securities Group Inc., sold 6,055 shares of ISRG, reducing its holdings, while other institutional investors also adjusted their positions in the company.
• The market movement could be attributed to profit-taking by institutional investors after a period of significant growth, despite positive earnings and analyst consensus ratings.
• The bearish trend might also be influenced by overall market conditions and investor sentiment towards the healthcare sector, as highlighted by the positive performance of other surgical equipment companies in Q3.

06.00.2026 - ISRG Stock was up 3.7%

• Despite significant insider selling and reduced stakes by asset management firms, major institutional investors increasing their positions in ISRG have likely instilled confidence in the market.
• The utilization of AI in driving growth and innovation within the medical sector has positioned companies like Intuitive Surgical for strong performance, attracting investors and contributing to the bullish movement.
• While the stock may be trading at a premium valuation with a high P/E ratio, the perceived undervaluation and potential for future growth due to product innovation and AI integration have likely fueled investor optimism, leading to the bullish market movement.

06.00.2026 - ISRG Stock was up 5.0%

• Noteworthy insider selling by Greenleaf Trust and Hennion & Walsh Asset Management Inc. did not deter overall market optimism towards ISRG today.
• Discussions around the utilization of Artificial Intelligence (AI) in the medical sector, including within companies like ISRG, likely influenced investor sentiment positively, reflecting interest in the company's growth prospects.
• ISRG's strong earnings report, surpassing revenue and EPS projections, is seen as a key factor reinforcing investor trust in the company's future performance.
• Variations in institutional investors' behavior, with some increasing stakes and others decreasing positions in ISRG, suggest diverse views on the company's long-term outlook. Nevertheless, the prevailing market sentiment remained favorable, supporting the bullish trend in ISRG.

14.00.2026 - ISRG Stock was down 5.5%

• Despite strong Q4 revenue and procedure growth, ISRG's stock saw a 6% decline in pre-market trading.
• Concerns regarding a slowdown in Ion endoluminal system placements, despite an increase in da Vinci system placements, appear to have fueled the bearish movement.
• Investor sentiment may have been influenced by the company's anticipation of a potential deceleration in da Vinci procedures growth for 2026.
• Watching for the stock's current undervaluation in comparison to estimated fair value, as well as expected advancements in AI-enabled surgery, could be crucial for potential future market movements.

13.02.2026 - ISRG Stock was down 4.7%

• The bearish movement in ISRG stock today could be attributed to:
• Mixed short-term share performance contrasting with significant long-term gains, raising concerns about potential valuation risks.
• Underperforming the general market, including the S&P 500, Dow, and Nasdaq, despite analysts anticipating strong earnings and revenue growth.
• The stock trading at a premium valuation compared to industry peers, potentially leading to profit-taking by investors.
• The acquisition of distributors in Southern Europe could be a positive long-term strategic move for ISRG, enhancing its direct presence in key markets and further solidifying its position in the region.
• Analysts' suggestions of undervaluation and expectations of revenue growth over the next 12 months may indicate a potential rebound in the stock price following today's decline.

02.00.2026 - ISRG Stock was down 1.2%

• The downturn in ISRG stock today may be linked to investors seizing profits following a recent rise in the stock price.
• Despite notable developments like a robust Q3 performance and increased interest from institutional investors, market sentiment could be swayed by overall uncertainty and volatility in the healthcare domain.
• The forthcoming Q4 earnings call set for January 22 might influence the stock's trajectory, as investors await insights on future growth prospects.
• The market's perception of ISRG could also be influenced by broader economic conditions and industry trends impacting healthcare and technology sectors.

22.09.2025 - ISRG Stock was up 16.5%

• ISRG exceeded Q3 earnings and revenue expectations, demonstrating robust financial performance.
• The introduction of the new da Vinci 5 system is stimulating hospital upgrades and premium pricing, potentially influencing the strong performance in Q3.
• Investors responded favorably to ISRG's solid Q3 results, resulting in a notable increase in the stock price.
• The company's consistent track record of impressive earnings and positive future prospects are likely driving the current bullish trend in ISRG's stock.

22.09.2025 - ISRG Stock was up 13.4%

• Third-quarter results revealed that Intuitive Surgical achieved $2.51 billion in revenue, a 23% increase from the previous year, surpassing predictions. The surge in da Vinci placements and global procedure growth fueled this remarkable performance.
• Despite a slight gross margin dip, the company's adjusted earnings of $2.40 per share exceeded forecasts, propelling ISRG stock by 17%.
• Investor optimism was evident as the market responded favorably to the earnings and revenue beat, showcasing confidence in Intuitive Surgical's financial prowess and industry prominence.
• With a track record of surpassing earnings estimates and a bright outlook, Intuitive Surgical is positioned to potentially surpass expectations in the future, contributing to the bullish trend in its stock value.

01.09.2025 - ISRG Stock was down 2.1%

• The bearish movement in ISRG stock may be linked to profit-taking by investors following a recent positive trend.
• Concerns over the national security review affecting the medical supply chain may have contributed to uncertainty in the healthcare sector, prompting a sell-off in ISRG shares.
• There might be worries among investors about potential disruptions in the supply chain of medical devices, including robotic surgery systems, which could impact ISRG's operations and revenue.
• The market's response to the national security review may have sparked a broader sell-off in healthcare stocks, including ISRG, as investors reevaluate the risks associated with the sector.